EUVIMEDEUVIMED entdecken
Open Access · CC0

Efficacy of commercial recombinant HVT vaccines against a North American clade 2.3.4.4b H5N1 highly pathogenic avian influenza virus in chickens

Jiho Lee iD, Chang-Won Lee, David L Suarez, Scott A Lee, Taejoong Kim iD, Erica Spackman iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0307100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Jiho Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: U.S. Department of Agriculture, Exotic and Emerging Avian Viral Diseases Unit, U.S. National Poultry Research Center, Agricultural Research Service, …. Hauptthemen laut MEDLINE: Chickens, Influenza in Birds, Influenza A Virus, H5N1 Subtype, Influenza Vaccines. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: Agricultural Research Service, Animal and Plant Health Inspection Service, U.S. Department of Energy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The outbreak of clade 2.3.4.4b H5 highly pathogenic avian influenza (HPAI) in North America that started in 2021 has increased interest in applying vaccination as a strategy to help control and prevent the disease in poultry. Two commercially available vaccines based on the recombinant herpes virus of turkeys (rHVT) vector were tested against a recent North American clade 2.3.4.4b H5 HPAI virus isolate: A/turkey/Indiana/22-003707-003/2022 H5N1 in specific pathogen free white leghorn (WL) chickens and commercial broiler chickens. One rHVT-H5 vaccine encodes a hemagglutinin (HA) gene designed by the computationally optimized broadly reactive antigen method (COBRA-HVT vaccine). The other encodes an HA gene of a clade 2.2 virus (2.2-HVT vaccine). There was 100% survival of both chicken types COBRA-HVT vaccinated groups and in the 2.2-HVT vaccinated groups there was 94.8% and 90% survival of the WL and broilers respectively. Compared to the 2.2-HVT vaccinated groups, WL in the COBRA-HVT vaccinated group shed significantly lower mean viral titers by the cloacal route and broilers shed significantly lower titers by the oropharyngeal route than broilers. Virus titers detected in oral and cloacal swabs were otherwise similar among both vaccine groups and chicken types. To assess antibody-based tests to identify birds that have been infected after vaccination (DIVA-VI), sera collected after the challenge were tested with enzyme-linked lectin assay-neuraminidase inhibition (ELLA-NI) for N1 neuraminidase antibody detection and by commercial ELISA for detection of antibodies to the NP protein. As early as 7 days post challenge (DPC) 100% of the chickens were positive by ELLA-NI. ELISA was less sensitive with a maximum of 75% positive at 10DPC in broilers vaccinated with 2.2-HVT. Both vaccines provided protection from challenge to both types of chickens and ELLA-NI was sensitive at identifying antibodies to the challenge virus therefore should be evaluated further for DIVA-VI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChickensInfluenza in BirdsInfluenza A Virus, H5N1 SubtypeInfluenza VaccinesAnimalsVaccines, SyntheticHemagglutinin Glycoproteins, Influenza VirusAntibodies, ViralNorth AmericaVaccinationPoultry DiseasesHerpesvirus 1, Meleagrid

Substanzen

Influenza VaccinesVaccines, SyntheticHemagglutinin Glycoproteins, Influenza VirusAntibodies, Viral

Autor:innen und Institutionen

  • U.S. Department of Agriculture, Exotic and Emerging Avian Viral Diseases Unit, U.S. National Poultry Research Center, Agricultural Research Service, Athens, Georgia, United States of America.
  • U.S. Department of Agriculture, Endemic Poultry Viral Diseases Unit, U.S. National Poultry Research Center, Agricultural Research Service, Athens, Georgia, United States of America.

ORCID-Profile: Jiho Lee, Taejoong Kim, Erica Spackman

Förderung

  • Agricultural Research Service
  • Animal and Plant Health Inspection Service
  • U.S. Department of Energy

Zitieren

APA

Lee, J., Lee, C. W., Suarez, D. L., Lee, S. A., Kim, T., & Spackman, E. (2024). Efficacy of commercial recombinant HVT vaccines against a North American clade 2.3.4.4b H5N1 highly pathogenic avian influenza virus in chickens. PLOS ONE. https://doi.org/10.1371/journal.pone.0307100

Vancouver

Lee J, Lee CW, Suarez DL, Lee SA, Kim T, Spackman E. Efficacy of commercial recombinant HVT vaccines against a North American clade 2.3.4.4b H5N1 highly pathogenic avian influenza virus in chickens. PLOS ONE. 2024. doi:10.1371/journal.pone.0307100

BibTeX
@article{Lee2024,
  author = {Lee, Jiho and Lee, Chang-Won and Suarez, David L and Lee, Scott A and Kim, Taejoong and Spackman, Erica},
  title = {Efficacy of commercial recombinant HVT vaccines against a North American clade 2.3.4.4b H5N1 highly pathogenic avian influenza virus in chickens},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0307100}
}
Kostenlos starten →